Idera Pharmaceuticals Inc (NASDAQ:IDRA)

3.13
Delayed Data
As of May 26
 0.00 / 0.00%
Today’s Change
1.94
Today|||52-Week Range
5.48
-29.02%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$368.9M

Company Description

Idera Pharmaceuticals, Inc. is a clinical stage biotechnology company, which is engaged in discovery, development and commercialization of novel nucleic acid therapeutics to treat patients with serious and life-threatening diseases. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal and James B. Wyngaarden in May 25, 1989 and is headquartered in Cambridge, MA.

Contact Information

Idera Pharmaceuticals, Inc.
167 Sidney Street
Cambridge Massachusetts 02139
P:(617) 679-5500
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Vincent J. MilanoPresident, Chief Executive Officer & Director
Louis J. ArcudiCFO, Secretary, Treasurer & SVP-Operations
Sudhir A. AgrawalDirector & President-Research
Kathryn HavilandVice President-Rare Diseases
Elizabeth EberhardtVice President-Oncology Programs

To view my watchlist

Not a member yet?

Sign up now for a free account